The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
EQRx, Inc. | Common Stock | 26886C107 | 24,750 | 5,000,000 | SH | SOLE | 5,000,000 | 0 | 0 | ||
Erasca, Inc. | Common Stock | 29479A108 | 2,438 | 312,500 | SH | SOLE | 312,500 | 0 | 0 | ||
Nautilus Biotechnology, Inc. | Common Stock | 63909J108 | 2,875 | 1,355,911 | SH | SOLE | 1,355,911 | 0 | 0 | ||
Robinhood Markets, Inc. | Class A Common Stock | 770700102 | 81,989 | 8,117,761 | SH | SOLE | 8,117,761 | 0 | 0 |